Huang, Chuanzhong
Wang, Ling
Chen, Huijing
Fu, Wankai
Shao, Lingdong
Zhou, Dongmei
Wu, Junxin
Ye, Yunbin
Funding for this research was provided by:
Sciences Foundation of Fujian University Cancer Hospital (2021YN17)
Joint Funds for the innovation of science and Technology of Fujian province (2022J011048, 2020J011113)
The National Natural Science Foundation of China (81472720)
Article History
Received: 11 July 2022
Accepted: 21 April 2023
First Online: 11 May 2023
Declarations
:
: All procedures for the rectal cancer validation were done in agreement with the Declaration of Helsinki and approved by the ethics committee of Fujian Cancer Hospital (ethics no. sq-2015–034-01), who approved a waiver of written consent to use the rectal tumor specimens. The study was reported in accordance with ARRIVE guidelines (ExternalRef removed). And the animal experiments were performed in accordance with the Animal Care Committee of Fujian Medical University.
: Not applicable.
: The authors declare no competing interests.